Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Jaume, Taura"'
Autor:
René A. J. Crans, Elise Wouters, Marta Valle-León, Jaume Taura, Caio M. Massari, Víctor Fernández-Dueñas, Christophe P. Stove, Francisco Ciruela
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/137c8a0904b543838a2edd3f05da1ad5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
René A. J. Crans, Elise Wouters, Marta Valle-León, Jaume Taura, Caio M. Massari, Víctor Fernández-Dueñas, Christophe P. Stove, Francisco Ciruela
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor control deficits, which is associated with the loss of striatal dopaminergic neurons from the substantia nigra. In parallel to dopaminergic denervation, there is an inc
Externí odkaz:
https://doaj.org/article/d78fedc97b28444c849c62f284c7c02b
Autor:
Hejian Xiong, Kevin A. Alberto, Jonghae Youn, Jaume Taura, Johannes Morstein, Xiuying Li, Yang Wang, Dirk Trauner, Paul A. Slesinger, Steven O. Nielsen, Zhenpeng Qin
Publikováno v:
Nano Research. 16:1033-1041
Precise modulation of neuronal activity by neuroactive molecules is essential for understanding brain circuits and behavior. However, tools for highly controllable molecular release are lacking. Here, we developed a photoswitchable nanovesicle with a
Autor:
Yulin Zhao, Jaume Taura, Ganesha Bantukallu, Juan Marugan, Avner Schlessinger, Paul A. Slesinger
Publikováno v:
Alcohol. 109:79-80
Autor:
Fabiana Núñez, Jaume Taura, Juan Camacho, Marc López-Cano, Víctor Fernández-Dueñas, Naomi Castro, Julio Castro, Francisco Ciruela
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Adenosine A2A receptor (A2AR) antagonists have emerged as complementary non-dopaminergic drugs to alleviate Parkinson’s disease (PD) symptomatology. Here, we characterize a novel non-xhantine non-furan A2AR antagonist, PBF509, as a potential pro-do
Externí odkaz:
https://doaj.org/article/d6349777c10d487da7f672d3cfcb5143
Autor:
Sergi Ferré, Jordi Bonaventura, Wendy Zhu, Candice Hatcher-Solis, Jaume Taura, César Quiroz, Ning-Sheng Cai, Estefanía Moreno, Verónica Casadó-Anguera, Alexxai V. Kravitz, Kimberly R. Thompson, Dardo G. Tomasi, Gemma Navarro, Arnau Cordomí, Leonardo Pardo, Carme Lluís, Carmen W. Dessauer, Nora D. Volkow, Vicent Casadó, Francisco Ciruela, Diomedes E. Logothetis, Daniel Zwilling
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
The central adenosine system and adenosine receptors play a fundamental role in the modulation of dopaminergic neurotransmission. This is mostly achieved by the strategic co-localization of different adenosine and dopamine receptor subtypes in the tw
Externí odkaz:
https://doaj.org/article/38b2b15a7fb34720abd17bdefcd1f850
Publikováno v:
Handbook of experimental pharmacology. 267
K
Publikováno v:
Neuromethods ISBN: 9781071615218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6242bd7bb79edae5b3b9e3108970b667
https://doi.org/10.1007/978-1-0716-1522-5_32
https://doi.org/10.1007/978-1-0716-1522-5_32
Publikováno v:
Pharmacology of Potassium Channels ISBN: 9783030840518
K+ channels enable potassium to flow across the membrane with great selectivity. There are four K+ channel families: voltage-gated K (Kv), calcium-activated (KCa), inwardly rectifying K (Kir), and two-pore domain potassium (K2P) channels. All four K+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a83e6c91ab215078f44c65d6e4f2c2eb
https://doi.org/10.1007/164_2021_460
https://doi.org/10.1007/164_2021_460